Last updated on August 2018

Samsca Post Marketing Surveillance Study


Brief description of study

This Post-Marketing Surveillance will be conducted in accordance with the local regulation of New Drug Re-examination. The surveillance will be conducted for 6 years of the re-examination period (01Sep2011~31Aug2017). Each subject will be observed at least for 4 days during the surveillance period.

Detailed Study Description

This study will be conducted as a prospective, single-arm, multicenter study. Findings on examination, diagnosis, opinions and observations implemented as per general medical practice during the observational period will be documented in the case report forms by the investigators or responsible staffs at the institution since the surveillance is an observational study.

Clinical Study Identifier: NCT02722863

Contact Investigators or Research Sites near you

Start Over

Yong Hwan Lee

Bong Seng Hospital
Busan, Korea, Republic of

Ki Sung Ahn

Daegu Catholic University Medical Center
Daegu, Korea, Republic of

Kang Wook Lee

Chungnam National University Hospital
Daejeon, Korea, Republic of

Jin Ho Hwang

Chung-Ang University Hospital
Seoul, Korea, Republic of

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.